Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

U-Screen DX Inc
Profile last edited on: 2/7/16      CAGE: 70QD9      UEI:

Business Identifier: DNA-based diagnostic technology for the early detection and management of cancer.
Year Founded
2013
First Award
2015
Latest Award
2015
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation

Location Information

3805 Old Easton Road
Doylestown, PA 18902
   (484) 467-0190
   N/A
   www.u-screendx.com
Location: Single
Congr. District: 01
County: Bucks

Public Profile

U-Screen DX is an early stage biotechnology company that is developing DNA_based diagnostic technology for the early detection and management of cancer. The tests are aimed at detecting cancers that have known genetic and epigenetic circulating DNA markers in urine and blood. The company is particulary focused on DNA-based tests for Hepatocellular carcinoma (HCC) or liver cancer.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$251,664
Phase II Dollars
$0
Total Awarded
$251,664

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2015 1 NIH $251,664
Project Title: Detection of Major HBV Integration Sites in Urine as a Biomarker for Hbv-Associated Liver Cancer

Key People / Management

  Selena Lin -- Co-Founder and CEO

  Wei Song -- Co-founder and President

  Ali Sajwani -- Chief Financial Officer

Company News

There are no news available.